Abstract
The article presents the first results of a study on a novel domestic topical adhesive haemostatic agent — «Haemostatic Film». The formulation is based on chitosan, arginine, polyethylene glycol, silicon dioxide, and iron chloride, structured as a double‑layered plate that ensures high adhesion to moist biological surfaces. The aim. To develop an effective, inexpensive, and atraumatic agent for controlling haemorrhages of various aetiologies (capillary, venous, arterial, and parenchymal). Materials and methods. The haemostatic efficacy and adhesive properties of the developed chitosan‑based composite agent were evaluated in vivo using models of major vessel injuries in deep wounds, as well as in cases of parenchymal organ damage. The study was conducted on 30 Wistar rats (both sexes, body weight 250‑300 g) and 12 male Vietnamese pot‑bellied pigs (body weight 40‑60 kg). Results. The application of the developed topical haemostatic agent demonstrated high haemostatic efficacy in both major vessel injuries and parenchymal organ wounds. Bleeding was completely stopped within several minutes, accompanied by the formation of a stable fibrin clot. Subsequent observation of the animals over 3‑4 hours revealed no signs of bleeding recurrence, confirming the reliability of haemostasis. The agent exhibited strong adhesion to the wound canal walls, providing mechanical stabilisation of damaged tissues. Conclusion. The developed adhesive haemostatic film, based on chitosan, arginine, polyethylene glycol, silicon dioxide, and iron chloride, demonstrated versatility in the studies (applicable to the liver, kidneys, spleen, and major vessels), the possibility of atraumatic removal, and adaptability — it can function as either temporary or definitive haemostasis.

This publication has 12 references indexed in Scilit: